The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Effect of Plasmodium falciparum sulfadoxine-pyrimethamine resistance on the effectiveness of intermittent preventive therapy for malaria in pregnancy in Africa: a systematic review and meta-analysis
Open accessAbstract
Background Resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine threatens the antimalarial effectiveness of intermittent preventive treatment during pregnancy (IPTp) in sub-Saharan Africa. We aimed to assess the associations between markers of sulfadoxine-pyrimethamine resistance in P falciparum and the effectiveness of sulfadoxine-pyrimethamine IPTp for malaria-associated outcomes. Methods For this systematic review and meta-analysis, we searched databases (from Jan 1, 1990 to March 1, 2018) for clinical studies (aggregated data) or surveys (individual participant data) that reported data on low birthweight (primary outcome) and malaria by sulfadoxine-pyrimethamine IPTp dose, and for studies that reported on molecular markers of sulfadoxine-pyrimethamine resistance. Studies that involved only HIV-infected women or combined interventions were excluded. We did a random-effects meta-analysis (clinical studies) or multivariate log-binomial regression (surveys) to obtain summarised dose-response data (relative risk reduction [RRR]) and multivariate meta-regression to explore the modifying effects of sulfadoxine-pyrimethamine resistance (as indicated by Ala437Gly, Lys540Glu, and Ala581Gly substitutions in the dhps gene). This study is registered with PROSPERO, number 42016035540. Findings Of 1097 records screened, 57 studies were included in the aggregated-data meta-analysis (including 59 457 births). The RRR for low birthweight declined with increasing prevalence of dhps Lys540Glu (p trend =0·0060) but not Ala437Gly (p trend =0·35). The RRR was 7% (95% CI 0 to 13) in areas of high resistance to sulfadoxine-pyrimethamine (Lys540Glu ≥90% in east and southern Africa; n=11), 21% (14 to 29) in moderate-resistance areas (Ala437Gly ≥90% [central and west Africa], or Lys540Glu ≥30% to <90% [east and southern Africa]; n=16), and 27% (21 to 33) in low-resistance areas (Ala437Gly <90% [central and west Africa], or Lys540Glu <30% [east and southern Africa]; n=30; p trend =0·0054 [univariate], I 2 =69·5%). The overall RRR in all resistance strata was 21% (17 to 25). In the analysis of individual participant data from 13 surveys (42 394 births), sulfadoxine-pyrimethamine IPTp was associated with reduced prevalence of low birthweight in areas with a Lys540Glu prevalence of more than 90% and Ala581Gly prevalence of less than 10% (RRR 10% [7 to 12]), but not in those with an Ala581Gly prevalence of 10% or higher (pooled Ala581Gly prevalence 37% [range 29 to 46]; RRR 0·5% [–16 to 14]; 2326 births). Interpretation The effectiveness of sulfadoxine-pyrimethamine IPTp is reduced in areas with high resistance to sulfadoxine-pyrimethamine among P falciparum parasites, but remains associated with reductions in low birthweight even in areas where dhps Lys540Glu prevalence exceeds 90% but where the sextuple-mutant parasite (harbouring the additional dhps Ala581Gly mutation) is uncommon. Therapeutic alternatives to sulfadoxine-pyrimethamine IPTp are needed in areas where the prevalence of the sextuple-mutant parasite exceeds 37%. Funding US Centers for Disease Control and Prevention, the Malaria in Pregnancy Consortium (funded through a grant from the Bill & Melinda Gates Foundation to the Liverpool School of Tropical Medicine), Worldwide Antimalarial Resistance Network, European and Developing Countries Clinical Trials Partnership.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methods for Trend Estimation from Summarized Dose-Response Data, with Applications to Meta-Analysis
Greenland, S., & Longnecker, M. P. (1992) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116237 · Cited by 2,353
Quantifying the Number of Pregnancies at Risk of Malaria in 2007: A Demographic Study
Dellicour, S., Tatem, A. J., Guerra, C. A., Snow, R. W., & ter Kuile, F. O. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000221 · Cited by 490
Eisele, T. P., Larsen, D. A., Anglewicz, P. A., Keating, J., Yukich, J., Bennett, A., Hutchinson, P., & Steketee, R. W. (2012) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(12)70222-0 · Cited by 253
Self-citationDesai, M., Gutman, J., Taylor, S. M., Wiegand, R. E., Khairallah, C., Kayentao, K., Ouma, P., Coulibaly, S. O., Kalilani, L., Mace, K. E., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ881 · Cited by 174
Self-citationHarrington, W. E., Mutabingwa, T. K., Kabyemela, E., Fried, M., & Duffy, P. E. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir376 · Cited by 156
Prevention of malaria in pregnancy
Desai, M., Hill, J., Fernandes, S., Walker, P., Pell, C., Gutman, J., Kayentao, K., Gonzalez, R., Webster, J., Greenwood, B., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30064-1 · Cited by 153
Self-citationChico, R. M., Cano, J., Ariti, C., Collier, T. J., Chandramohan, D., Roper, C., & Greenwood, B. (2015) · Tropical Medicine & International Health · doi:10.1111/tmi.12595 · Cited by 77
Self-citationKalilani, L., Mofolo, I., Chaponda, M., Rogerson, S. J., Alker, A. P., Kwiek, J. J., & Meshnick, S. R. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001166 · Cited by 75
Self-citation
Cited by
Drug treatment and prevention of malaria in pregnancy: a critical review of the guidelines
Al Khaja, K. A. J., & Sequeira, R. P. (2021) · Malaria Journal · doi:10.1186/s12936-020-03565-2 · Cited by 39
Gutman, J. R., Khairallah, C., Stepniewska, K., Tagbor, H., Madanitsa, M., Cairns, M., L'lanziva, A. J., Kalilani, L., Otieno, K., Mwapasa, V., et al. (2021) · eClinicalMedicine · doi:10.1016/j.eclinm.2021.101160 · Cited by 33
Self-citationCombining malaria vaccination with chemoprevention: a promising new approach to malaria control.
Greenwood, B., Cairns, M., Chaponda, M., Chico, R. M., Dicko, A., Ouedraogo, J.-B., Phiri, K. S., ter Kuile, F. O., & Chandramohan, D. (2021) · Malaria Journal · doi:10.1186/s12936-021-03888-8 · Cited by 32
Kayiba, N. K., Yobi, D. M., Tchakounang, V. R. K., Mvumbi, D. M., Kabututu, P. Z., Devleesschauwer, B., Mukomena, E. S., DeMol, P., Hayette, M.-P., Mvumbi, G. L., et al. (2021) · Infection, Genetics and Evolution · doi:10.1016/j.meegid.2021.105009 · Cited by 22
Malaria – Current Treatment Options
Virginia, D. M., Shegokar, R., & Pathak, Y. (2023) · Malarial Drug Delivery Systems · doi:10.1007/978-3-031-15848-3_4 · Cited by 1
Metadata
- Authors
- van Eijk, A. M., Larsen, D. A., Kayentao, K., Koshy, G., Slaughter, D. E. C., Roper, C., Okell, L. C., Desai, M., Gutman, J., Khairallah, C., Rogerson, S. J., Hopkins Sibley, C., Meshnick, S. R., Taylor, S. M., & ter Kuile, F. O.
- Venue
- The Lancet Infectious Diseases
- Publisher
- Elsevier BV
- Published
- 2019-05
- Volume
- 19
- Issue
- 5
- Pages
- 546-556
- ISSN
- 1473-3099 (ISSN-L)
- OpenAlex
- W2922724938
- Cited by
- 160
- References
- 8
- FWCI
- 4.35
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effect of Plasmodium falciparum sulfadoxine-pyrimethamine resistance on the effectiveness of intermittent preventive therapy for malaria in pregnancy in Africa: a systematic review and meta-analysis. https://app.cochat.ai/papers/10.1016/s1473-3099(18)30732-1
- The paper
- van Eijk, A. M., Larsen, D. A., Kayentao, K., Koshy, G., Slaughter, D. E. C., Roper, C., Okell, L. C., Desai, M., Gutman, J., Khairallah, C., Rogerson, S. J., Hopkins Sibley, C., Meshnick, S. R., Taylor, S. M., & ter Kuile, F. O. (2019). Effect of Plasmodium falciparum sulfadoxine-pyrimethamine resistance on the effectiveness of intermittent preventive therapy for malaria in pregnancy in Africa: a systematic review and meta-analysis. The Lancet Infectious Diseases. https://doi.org/10.1016/s1473-3099(18)30732-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.